Clinical Trials

A Randomized, Multicenter, Double Blind, Phase III Study of Nivolumab or Placebo in Subjects with Resected Lower Esophageal, or Gastroesophageal Junction Cancer


Study ID
Bristol-Myers Squibb CA209-577

NCT Number
NCT02743494 (Click on the NCT number for more information about the trial)

Research Study Number
2016-0138

Principle Investigator
Dr. Martin Gutierrez

Phase
III

Sponsor
Bristol-Myers Squibb


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now